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Introduction: Extended-spectrum beta-lactamases (ESBL) and AmpC beta-lactamases (AmpC) are of concern
for veterinary and public health because of their ability to cause treatment failure due to antimicrobial
resistance in Enterobacteriaceae. The main objective was to assess the relative contribution (RC) of different
types of meat to the exposure of consumers to ESBL/AmpC and their potential importance for human
infections in Denmark.
Material and methods: The prevalence of each genotype of ESBL/AmpC-producing E. coli in imported and
nationally produced broiler meat, pork and beef was weighted by the meat consumption patterns. Data
originated from the Danish surveillance program for antibiotic use and antibiotic resistance (DANMAP) from
2009 to 2011. DANMAP also provided data about human ESBL/AmpC cases in 2011, which were used to
assess a possible genotype overlap. Uncertainty about the occurrence of ESBL/AmpC-producingE. coli inmeat
was assessed by inspecting beta distributions given the available data of the genotypes in each type of meat.
Results and discussion: Broiler meat represented the largest part (83.8%) of the estimated ESBL/AmpC-
contaminated pool of meat compared to pork (12.5%) and beef (3.7%). CMY-2 was the genotype with
the highest RC to human exposure (58.3%). However, this genotype is rarely found in human infections in
Denmark.
Conclusion: The overlap between ESBL/AmpC genotypes in meat and human E. coli infections was limited.
This suggests that meat might constitute a less important source of ESBL/AmpC exposure to humans in
Denmark than previously thought maybe because the use of cephalosporins is restricted in cattle and banned
in poultry and pigs. Nonetheless, more detailed surveillance data are required to determine the contribution
of meat compared to other sources, such as travelling, pets, water resources, community and hospitals in the
pursuit of a full source attribution model.
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E
xtended-spectrum beta-lactamases (ESBL) were
defined by the EFSA Panel on Biological Hazards
(BIOHAZ) as plasmid-encoded enzymes found in
the bacterial family Enterobacteriaceae, commonly in
Escherichia coli and Klebsiella pneumonia. ESBL confer
resistance to avariety of beta-lactam antibiotics, including
penicillins; second-, third-, and fourth-generation cepha-
losporins; andmonobactams (1). The BIOHAZ panel also
stated that AmpC beta-lactamases (AmpC) are intrinsic
cephalosporinases found on the chromosomal DNA of
many gram-negative bacteria. However, the number of
AmpC enzymes that are plasmid borne is increasing (1).
An example of such plasmidic AmpC is CMY-2.
Burden of disease
The World Health Organization (WHO) estimated 25,000
deaths each year in the European Union (EU) due
to infections with antibiotic-resistant bacteria (2). The
increase of antimicrobial resistance caused by ESBL/
AmpC is particularly worrying due to their resistance
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to third- and fourth-generation cephalosporins, which
have been considered critically important to human
medicine (3).
Infections caused by ESBL/AmpC-producing bacteria
are increasing worldwide (4). The European Antimicro-
bial Resistance Surveillance Network (EARS-Net) stated
that no country among the 28 countries reporting to
this program has demonstrated decreasing trends of
third-generation cephalosporin-resistant E. coli over the
past few years (5). Moreover, in 2011, more than half
of the countries reported proportions between 85 and
100% of third-generation cephalosporin-resistant E. coli
to be ESBL-producing (5). In Denmark, a steady increase
of third-generation cephalosporin-resistant E. coli from
human bloodstream infections has been observed from
2005 (1.1%) through 2011 (8.5%) (6).
The importance of the increase of ESBL/AmpC among
E. coli septicemias can also be reflected in the augmented
case fatality risk (7), although it should be noted that
these bacteraemic cases are often associated with a critical
underlying disease, delay in appropriate treatment and
older age (8).
In general, the economic burden of antimicrobial
resistance is significant (9). Moreover, ESBL/AmpC resis-
tance leads to an increase in the use of carbapenems
(4). The use of this class of drugs is related to the
emergence of carbapenemases (10), which have the ability
to hydrolyze all the beta-lactams and are therefore of
concern (1).
Possible ESBL/AmpC-producing bacteria
sources
There are several potential ESBL/AmpC-producing bac-
teria sources that can be summarized in five major groups:
foodborne, direct animal-to-human transmission, human-
to-human transmission, environment and infections ob-
tained abroad during travelling. Travelling is considered a
source by itself since surveillance programs are normally
set at a national level. Moreover, it is more difficult to
unveil the specific source when infection is acquired
abroad. To our knowledge, the true importance of each
of these possible sources for ESBL/AmpC dissemination
and their relative relevance for human cases is unknown.
Recently, a possible link to food and food-producing
animals was made (1), stressing the importance of scruti-
nizing the role of food animal products to human ESBL/
AmpC-producing bacterial infections.
The Danish situation
Denmark, like other Nordic countries, has always been
considered to have a low prevalence of antimicrobial re-
sistance in the livestock population, due to the conscious
use and restrictive measures related to antibiotics. The
‘Yellow card’ initiative (11) and the voluntary ban on
the use of cephalosporin in pigs (12) are examples of the
precautionary Danish policy regarding the antimicrobial
use in animal production.
From 2000 to 2008, DANMAP reports consis-
tently showed a very low prevalence of third-generation
cephalosporin-resistant bacteria both in live animals and
in Danish meat (below 2% of positive samples) (1321).
Meat samples with 5 g of weight were collected at whole-
sale and retail outlets and a non-selective culture method
was used.
To detect ESBL/AmpC-producing bacteria, an antibio-
tic enriched culture method is preferred (1). In 2009, the
first surveillance study using an enriched culture method
was performed, followed by a genetic background inves-
tigation (22). In relation to the sample weight and place of
sample collection, the original procedure was kept. Since
then, this protocol has been repeated yearly, revealing an
increasing prevalence of ESBL/AmpC-producingE. coli in
Danish broiler meat from 3% in 2009 (data not published)
to 44% in 2011 (23). In the same period, the prevalence in
imported broiler meat ranged from 36 to 50% (2224).
This has raised concern that meat may be an increasingly
important source of human cases in Denmark.
Hence, the aim of this study was to determine the
relative contribution (RC) of various meat types to the
exposure of Danish meat consumers to ESBL/AmpC-
producing E. coli and their potential importance for
human infections in Denmark.
Material and methods
A relative exposure assessment was performed. The ap-
proach was to compare the distributions of genotypes in
humans and the most common meat sources in Denmark.
Meat consumption patterns
Data about the fresh and frozen meat available for
consumption in 2009, 2010 and 2011 from the ‘Annual
Report on Zoonoses in Denmark 2011’ were consulted
and divided into six categories: imported and domes-
tically produced broiler meat, pork and beef (25) (Fig. 1).
Consumption was calculated as:
Domestically produced  exported imported (25).
ESBL/AmpC-producing E. coli occurrence in meat
The data describing the ESBL/AmpC prevalence were
collected from the Danish surveillance program for
antibiotic use and antibiotic resistance (2224). In the
DANMAP program, meat samples (5 g per sample for
all three species) are collected at wholesale/retail level
and detection of ESBL/AmpC-producing E. coli is
conducted using a selective culture method using anti-
microbials. This is a qualitative method with a very high
sensitivity.
RC of each type of meat to human exposure
To calculate the contribution of each type of meat and
each genotype to human exposure, the prevalence of
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ESBL/AmpC genotypes was weighted by the amount of
meat available for consumption: Weighted Prevalence
(WP)Prevalence * Meat available for consumption.
All the WPs were added up to obtain the total pool of
ESBL/AmpC in meat (TP). Finally, the WP of each
genotype was divided by the ESBL/AmpC Total Pool:
RCWP/TP.
Due to the low number of positive samples for pork
and beef and the low number of samples tested in general,
the 3 years of sampling were analyzed collectively. How-
ever, the described procedure was also applied to each
year separately.
Uncertainty distributions
Using the software @Risk 4.5 Palisade Corporation†,
beta distributions were created to assess the 95% cred-
ibility interval (CI) for each genotype. The main objective
of this procedure was to conduct an uncertainty analysis
and hereby estimate how high the true prevalence could
be given the available data. Beta distributions were used
in previous risk assessments to take into account the
uncertainty and variability of estimates (26).
The beta distributions were made through a simula-
tion using 1,000,000 iterations. The distributions were
defined by (s1, ns1), where s represents the
number of positive samples for each genotype in each
type of meat from 2009 to 2011, and n represents the total
number of samples tested for ESBL/AmpC-producing
E. coli in each type of meat within the same 3-year
period.
This procedure was of particular relevance because
some genotypes have not been found in the Danish
sampling surveillance, but still may have been present in
meat and could have played a role for ESBL/AmpC-
producing E. coli human cases. Their distribution was set
as (01, n01). Some genotypes were not found in
meat during the surveillance program, but were found in
live animals. The higher the number of samples tested and
found negative, the lower the maximum prevalence that
could be in the meat.
Results
RC of each type of meat to human exposure
During the period 20092011, broiler meat contributed
the most to the total human exposure to ESBL/AmpC
representing 83.8% of the total exposure. Danish broiler
meat contributed with 37.0% and imported broiler meat
with 46.8%. Danish and imported pork constituted 6.2
and 6.3% of the ESBL/AmpC positive meat available for
consumption, respectively. Beef was less important,
representing 1.2% in beef of Danish origin and 2.5% of
imported origin. The RC of Danish broiler meat in-
creased markedly from 2009 to 2011, while the RC of
pork and imported broiler meat decreased in the same
period (Fig. 2).
The RC of each genotype varied among the 3 years
(Table 1). Most important was the increase in the role of
CMY-2 in Danish broiler meat from 4.7% in 2009 to
11.8% in 2010, increasing to 53.5% of the total exposure
in 2011. Moreover, CMY-2 constituted the genotype that
meat consumers were most exposed to (58.3% across the
3-year period). Broiler meat was the source that con-
tributed the most to this specific exposure (56.8% from
broiler meat, 0.8% from pork, and 0.7% from beef).
CTX-M-1 was the most frequently isolated genotype in
pork and beef at 8.2 and 2.5% of the total exposure,
respectively. Including broiler meat, CTX-M-1 repre-
sented 28.8% of the total ESBL/AmpC-positive meat on
the Danish market from 2009 to 2011.
Considering the origin of positive meat for ESBL/
AmpC, a major shift occurred from 2010 to 2011. Both in
2009 and 2010, Danish meat represented less than one
third of the ESBL/AmpC meat contributing to human
exposure (31.4 and 23.0%, respectively). In 2011, the RC
Fig. 1. Fresh and frozen meat available for consumption in Denmark of Danish (DK) and imported (IMP) origin between 2009 and
2011. Source: DTU 2011.
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for human exposure of the Danish meat rose to 58.9%
and the imported meat declined to 41.1%. However,
across the 3-year period, imported meat still contributed
the most to human exposure (55.7%).
Genotype overlapping between meat and human
infections
In humans, the so-called ‘pandemic’ CTX-M-15 geno-
type dominated in 2011 in Denmark, both in blood
and urine ESBL-producing E. coli isolates, with 68.0 and
59.3%, respectively (23) (Fig. 3). CTX-M-1 was detected
in 7.3% of urine and 8.0% of blood isolates (23).
CMY-2 was detected in human infections, but it was
not possible to calculate its relative prevalence in urinary
tract infections and septicemias. Nevertheless, the num-
ber of positive samples was low (data not published).
Considering both the human data and the results from
the RC of each genotype to the human exposure through
meat, the genotype overlapping between the two reser-
voirs is low.
Prevalence estimations for each genotype
CTX-M-15 was the genotype most commonly found in
human cases. It was found on rare occasions in Danish
pigs and cattle at slaughter: two positive samples in 2009
(n786) and one in 2011 (n777) in pigs, and one
positive sample in 2010 (n192) and another in 2011
(n186) in cattle. However, this genotype had not been
detected in meat samples previously. Through our calcula-
tions, this ESBL gene was estimated to be present in
Danish pork and beef with prevalences below 0.7 and
1.0%, respectively, given the available data (Table 2).
The prevalence of CTX-M-1 was 0.2% in imported
pork (23), but there was a high degree of uncertainty due
to the low number of positive samples and total number
of samples taken. The estimated upper limit of prevalence
for this genotype was 3.8% in imported pork. CTX-M-14
was also estimated to be present in imported pork, with
a prevalence below 1.3%. It should be noted that both
CTX-M-1 and CTX-M-14 have been found in meat and
in human cases in Denmark.
Imported broiler meat was the type of meat where
the highest diversity of ESBL/AmpC genes was found
in the DANMAP program. CMY-2 and CTX-M-1 had
an upper limit of the estimated prevalence of 24.5 and
17.9%, respectively.
Discussion
We evaluated the RC of various types of meat for the
exposure of consumers to ESBL/AmpC-producing E. coli
and their potential importance for human cases. We
concluded that broiler meat was the type of meat that
contributed the most to human exposure (83.8%), while
CMY-2 was the genotype with the highest RC (58.3% of
the total exposure through meat). However, this genotype
Fig. 2. Relative contribution of each type of meat and their respective origin to human ESBL/AmpC- producing E. coli exposure, based
on Danish data from 2009 to 2011 (Danmap, 2009, 2010, 2011).
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has only been found on rare occasions in Danish human
infections.
A definitive cause-effect association cannot be
established through our approach. A genotype overlay
is not proof that the sources were the actual route
of exposure, so overlaps are indicative of a physical
link between the source and the exposed individual that
warrant further investigations. On the contrary, the
absence of a genotype overlap, considering an appro-
priate sample scheme, provides evidence against a pos-
sible link. Therefore, inferences can be made with
caution. With this in mind, the limited genotype overlap
between the two reservoirs indicates that meat might
play a minor role for human cases of ESBL/AmpC-
producing E. coli.
Data and methods
The meat consumption patterns were measured as the
fresh and frozen meat available for consumption, not as
the meat that was actually consumed. However, it was
assumed that waste of meat occurred in the same
proportion for all types of meat.
The bacterial capacity to survive in frozen and
fresh meat might differ (27). However, data were not
Table 1. Relative contribution (RC) of each type of meat for human exposure considering the origin and the genotypes found in
DANMAP surveillance from 2009 to 2011
RC for human exposure (%) RC for human exposure (%) RC for human exposure (%)
Meat type 2009 2010 2011 20092011 Origin 2009 2010 2011 20092011 Genotype 2009 2010 2011 20092011
Pork 24.2 13.8 8.4 12.5
CTX-M-1 0.0 6.2 2.5 3.1
Danish 18.9 6.2 2.5 6.2 CTX-M-2 12.9 0.0 0.0 2.1
Others1 6.0 0.0 0.0 1.0
CTX-M-1 2.7 7.6 4.5 5.1
Imported 5.3 7.6 6.0 6.3 CMY-2 0.0 0.0 1.5 0.8
CTX-M-14 2.7 0.0 0.0 0.4
Beef 8.8 5.4 1.4 3.7
Danish 3.2 2.4 0.00 1.8 CMY-2 0.0 2.4 0.0 0.7
Others2 3.2 0.0 0.0 0.5
Imported 5.7 3.1 1.4 2.5 CTX-M-1 5.7 3.1 1.4 2.5
Broiler meat 67.0 80.8 90.2 83.8
Danish 9.3 14.5 56.5 37.0 CMY-2 4.7 11.8 53.5 33.8
CTX-M-1 4.7 2.7 3.0 3.2
Imported 57.6 66.3 33.7 46.8 CMY-2 27.6 24.7 20.8 23.0
CTX-M-1 14.2 29.3 7.9 15.0
SHV-12 9.2 6.5 4.1 5.6
Others3 5.0 4.1 1.0 2.5
CTX-M-2 1.6 1.7 0.0 0.8
1Unknown genotypes (i.e. when it was impossible to determine a specific genotype).
2TEM-52 and unknown genotypes.
3TEM-20, TEM-52, up-regulated AmpC and unknown genotypes.
Fig. 3. (A) Proportion of various genotypes detected in ESBL-producing E. coli urinary tract infections in humans in Denmark in 2011.
(B) Proportion of various genotypes detected in ESBL-producing E. coli bloodstream infections in humans in Denmark in 2011.
Source: DANMAP 2011.
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Table 2. Lower limit, mode and upper limit of prevalence calculated for each genotype in each type of meat through beta distribution with a 95% CI
Beta distribution of genotype prevalence
Meat type Origin
Total number of
samples for each
type of meat n
Number of positive
samples for each
type of meat
Prevalence
20092011
(%) Genotype
Number of positive
samples for each
genotype s (prevalence,%)
Lower limit of
prevalence
(%)
Mode of
prevalence
(%)
Upper limit of
prevalence
(%)
Detected in
humans
(DANMAP 2011)
Pork
Danish 562 7 1.2
CTX-M-1 4 (0.7) 0.4 0.7 1.8 Yes
CTX-M-2 2 (0.4) 0.2 0.4 1.2 No
Unknown 1 (0.2) 0.0 0.2 0.9 N/A1
Others 0 (0.0) 0.0 0.0 0.7 N/A2
Imported 448 11 2.4
CTX-M-1 9 (2.0) 1.1 2.0 3.8 Yes
CTX-M-14 1 (0.2) 0.0 0.2 1.3 Yes
CMY-2 1 (0.2) 0.0 0.2 1.3 Yes3
Others 0 (0.0) 0.0 0.0 0.9 N/A
Beef
Danish 382 2 0.5
TEM-52 1 (0.3) 0.0 0.3 1.3 No
CMY-2 1 (0.2) 0.0 0.3 1.3 N/A
Others 0 (0.0) 0.0 0.0 1.0 N/A
Imported 298 3 1.1
CTX-M-1 3 (1.1) 0.3 1.0 3.0 Yes
Others 0 (0.0) 0.0 0.0 1.4 N/A
Broiler
meat
CMY-2 70 (16.0) 12.7 16.1 19.8 Yes
Danish 440 78 17.8 CTX-M-1 8 (1.8) 0.9 1.8 3.6 Yes
Others 0 (0.0) 0.0 0.0 0.9 N/A
CMY-2 120 (21.0) 17.9 21.0 24.5 Yes
CTX-M-1 84 (14.7) 12.1 14.5 17.9 Yes
SHV-12 31 (5.4) 3.9 5.4 7.5 No
Imported 571 255 44.7 TEM-52 6 (1.1) 0.5 1.1 2.3 No
Unknown 6 (1.1) 0.5 1.1 2.3 N/A
CTX-M-2 5 (0.9) 0.4 0.9 1.9 No
TEM-20 1 (0.2) 0.0 0.2 0.9 No
Up-regulated
AmpC
1 (0.2) 0.0 0.2 0.9 No
SHV-2a 1 (0.2) 0.0 0.2 0.9 No
Others 0 (0.0) 0.0 0.0 0.7 N/A
1N/A is applied to ‘Unknown’ genotypes found in meat in DANMAP. It was not possible to determine which was the genotype detected.
2N/A is applied to ‘Others’, since it may include genotypes that were present or not in human samples.
3CMY-2 was detected in humans but its prevalence was not possible to calculate. However, it is known that few positive CMY-2 samples were detected. The total number of samples for
each type of meat performed from 2009 to 2011 for DANMAP is represented by n, while s is the number of positive samples for each genotype in each type of meat. For a better
understanding and comparison with the uncertainty analysis the genotype prevalence within each type of meat is shown.
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available to take the survival in different types of meat
and storage types into account. Therefore, this might
result in potential bias.
It was not possible to extend the study to other types
of meat, such as turkey or horse meat, due to the lack of
data on ESBL/AmpC-producing E. coli prevalences.
Nonetheless, the presented exposure assessment covered
the three types of meat that represent the vast majority of
meat consumed in Denmark.
The RC of meat to human exposure
Some changes were observed in the RC of each genotype
from 2009 to 2011. Mainly minor shifts happened due to
the sporadic detection of some ESBL/AmpC genes, and
these were probably due to the limited sample sizes. The
most evident change occurred with the increasing con-
tribution of CMY-2 in Danish broiler meat from 4.7% in
2009 to 53.5% in 2011. This was due to the increasing
prevalence of this genotype in Danish broiler meat,
especially from 2010 to 2011 (23).
Considering that cephalosporins have not been used in
poultry in Denmark for more than 10 years, it is possible
that the origin of the problem is upstream in the
production pyramid. This hypothesis has also arisen in
Sweden (28, 29). Danish and Swedish broiler parents
come from the same Swedish breeding stock, which in
turn is supplied by a Scottish grand-parent breeding
company, where cephalosporins have been used prophy-
lactically until recently. In Denmark, an all in/all out
policy and strict biosecurity measures are implemented.
Nevertheless, transmission between flocks might be
possible and should be dealt with: proper actions related
to all logistics behind broiler feeding, technical support
and broiler transportation to the slaughterhouses (cages
and trucks) which might help to limit the dissemination
between flocks. Moreover, it should be investigated
whether the animal feed might act as an important
source of ESBL/AmpC-producing E. coli. However, the
fact that CMY-2 and CTX-M-1 were also the genotypes
detected in Swedish broiler meat (30) and both of them
being the only genotypes persistently detected in Danish
broiler meat from 2009 to 2011, supports the hypothesis
of a common source upstream in the production pyr-
amid. In contrast, imported broiler meat presented a
substantial variety of genotypes (2224), possibly due to
the different importing countries and various causes of
ESBL/AmpC emergence.
In general, the use of other antimicrobials in the broiler
production may facilitate the spread and maintenance
of ESBL/AmpC-producing E. coli through co-resistance
patterns (29). Moreover, cross-contamination through the
environment, humans and animals, as well as off-label use
of cephalosporins are other ways of spreading resistance.
Denmark has one of the lowest antimicrobial uses in
livestock of the EU and demonstrates a very prudent use
of cephalosporins in animals (31). The discontinuation
of the use of cephalosporins in 2010 in pigs is the
most likely explanation for the reduction in the ESBL/
AmpC-producing E. coli prevalence seen in pigs in 2011
(12). Other factors could also have contributed to this
diminution, that is, the ‘Yellow card’ initiative, which
took place almost at the same time and initially led to a
25% decrease in the use of antimicrobials in pigs (11, 32).
The homogeneity of the ESBL/AmpC-producingE. coli
genotypes from imported beef is mostly likely a result of
the low number of positive samples: one positive sample
per year out of 298 samples analyzed. In Danish beef just
two positive samples from different genotypes were found
from 2009 to 2011 (data not published). The total number
of Danish beef collected samples during the 3-year period
was 398. Due to the low numberof positive samples, beef is
the type of meat in which the uncertainty about the true
ESBL/AmpC genotype distribution is the highest.
Genotype overlaps between meat and human
infections
In humans, the so-called ‘pandemic’ CTX-M-15 genotype
dominated in 2011 in Denmark, both in blood and urine
ESBL-producing E. coli isolates, with 68.0 and 59.3%,
respectively (23) (Fig. 3). CTX-M-1 was detected in 7.3%
of urine and 8.0%of blood isolates (23).However, it should
be noted that, particularly for human ESBL-producing
E. coli septicemia, the numberof cases that these results are
based on is quite small (n25). Consequently, it is possible
that the true ESBL genotype distribution in Denmark is
slightly different from what was found, and some geno-
types may not have been detected.
ESBL/AmpC genes found in humans and meat were, as
previously described, only congruent to a limited extent.
Although some genotypes were not found in meat, they
were found in live animals, indicating their possible
presence in meat. That is the case of CTX-M-15, which
was detected in very low prevalence in Danish pigs and
Danish cattle. Its low prevalence probably explains why it
was not detected inmeat. Thiswas one of themainmotives
that propelled us to perform an uncertainty analysis
through the use of beta distributions. As expected, the
mode prevalence was equal or very similar to the
prevalence found in DANMAP and the uncertainty was
higher with smaller sample sizes. The maximum expected
prevalence for ESBL/AmpC genes not detected in meat,
considering the DANMAP sampling within the 3-year
period, was 0.7% for Danish pork, 0.9% for imported
pork, 1.0% for Danish beef, 1.4% for imported beef, 0.9%
for Danish broiler meat and 0.7% for imported broiler
meat. Through our calculations, these are the upper 95%
credibility limits for the expected prevalences for CTX-M-
15 in each type of meat. Such low prevalence points
against a relevant role of meat for the CTX-M-15-
producing E. coli infections in humans. Nonetheless,
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more should be known about the duration of carriage,
dominance in the human gut microflora and dif-
ferent reservoir adaptability and ESBL/AmpC-producing
E. coli’s diverse ability to survive in the human gut
environment.
CMY-2 was detected in human infections, but it was
not possible to calculate its relative prevalence in urinary
tract infections and septicemias due to lack of infor-
mation. Nevertheless, the positive number of samples
in humans was low (data not published). Considering
the contribution of CMY-2-producing E. coli for human
exposure through meat, its relative prevalence in human
infections must be calculated in the upcoming years.
A quantitative exposure assessment to third-generation
cephalosporin-resistant E. coli through the consumption
of broiler meat performed in Belgium (33) also high-
lighted the lack of some important data to evaluate the
impact of animal foodborne sources to human exposure.
Control options
Our results suggest that meat does not have as high
impact on human ESBL/AmpC-producing E. coli infec-
tions in Denmark as previously thought. This might be
related to the actions taken in Denmark to limit the use
of cephalosporins in livestock. Hence, this does not
exclude the importance of animal production, and even
meat, for ESBL/AmpC dissemination, so a precautionary
approach should be taken.
In Denmark, there are limited additional options to
control ESBL/AmpC occurrence through the reduc-
tion of the use of cephalosporins in livestock. However,
other antimicrobials can co-select ESBL/AmpC-producing
bacteria. Therefore, measures to promote the reduction
of antimicrobial use in general, such as the ‘Yellow card’
scheme, may have some influence. Regarding the high
ESBL/AmpC-producing E. coli prevalences in Danish
broiler meat, measures have recently been taken to
assure the non-use of cephalosporins in the top of the
production pyramid (Jan Dahl, Danish Agriculture and
Food Council, personal communication, 2013).
Moreover, actions taken to limit cross-contamination
during slaughter should always be encouraged.
A judicious use of resources must be done. In that
sense, the role of other sources should be assessed in-
cluding the annual human consumption of cephalospor-
ins. In 2009, the human consumption of cephalosporins
in Denmark was 2,740 kg compared to 95 kg in pigs (22).
This would allow us to point to the reservoir where
most effort should be applied to control ESBL/AmpC-
producing E. coli. Table 3 presents some general measures
to control ESBL/AmpC-producing E. coli and ESBL/
AmpC-producing bacteria in Denmark.
Meat might be the source for at least a small part of
the human cases, but to obtain more precise conclusions,
further studies are needed. ESBL/AmpC-producing bac-
teria is a complex subject and their emergence, ecology,
and dynamics is nowadays poorly understood.
A wider study about the ESBL/AmpC genotypes in
human cases in Denmark is recommended including an
extensive characterization of human patients, that is,
through a detailed and recorded patient history which
may enable further investigations on the epidemiology of
ESBL/AmpC-producing bacteria. Additionally, studying
the risk factors for the colonization of healthy humans
could be a relevant step for source attribution and im-
portant to prioritize control measures. However, new and
more discriminatory molecular methods may be needed
to distinguish different reservoirs and transmission
routes.
Table 3. Suggested measures to control ESBL/AmpC-producing bacteria in Denmark
Possible source Measures
Human-to-human and nosocomial Improve hospital hygiene
infections Stricter guidelines, both for hospital and community use of cephalosporins
Animal-to-human transmission Stricter guidelines for the use of cephalosporins in pets
Travelling International measures to control ESBL/AmpC-producing bacteria
Advice to travelers about hygiene measures to prevent becoming colonized with ESBL/AmpC-
producing bacteria
Environment Reduce the use of cephalosporins and antimicrobials in general; this should decrease ESBL/AmpC-
producing bacteria dissemination
Stricter evaluation of wastewater, including microbiological criteria and control of resistant bacteria
Foodborne Avoid use of cephalosporins and reduce the use other antimicrobials to as little as possible but as
much as necessary in livestock
Production measures to reduce ESBL/AmpC-producing bacteria dissemination
Improve slaughter hygiene
Decontamination after slaughter
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The relevance of ESBL/AmpC-producing bacteria
carriage for the occurrence of community acquired
and nosocomial infections should also be assessed.
This includes not only further investigations on the risk
of transmission of ESBL/AmpC genetic material from
bacteria in consumed food to commensal gut flora, but
also an assessment of the relevance of ESBL/AmpC-
producing bacteria carriage for the development of severe
infections caused by the same bacteria.
Conclusion
In this study, broiler meat was the type of meat with the
highest RC for human exposure (83.8%), followed by
pork (12.5%) and beef (3.7%).
We conclude that the genotype overlap between human
and meat from poultry, pigs and cattle is low, suggesting
that meat might not have such a relevant role for ESBL/
AmpC-producing E. coli human infections in Denmark
in 20092011, as previously thought. This is most likely
related to the limited use of cephalosporins in Danish
livestock.
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